First Trust Advisors
EPZM

First Trust Advisors’s Epizyme, Inc EPZM Stock Holding History

First Trust Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-46,148
Closed -$741K – 2537
2020
Q2 		$741K Sell
46,148
-71,590
-61% -$1.25M ﹤0.01% 1864
2020
Q1 		$1.83M Buy
117,738
+54,166
+85% +$1.16M ﹤0.01% 1311
2019
Q4 		$1.56M Buy
+63,572
New +$944K ﹤0.01% 1678
2018
Q3 		– Sell
-43,292
Closed -$587K – 2561
2018
Q2 		$587K Buy
+43,292
New +$674K ﹤0.01% 2099

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

First Trust Advisors's EPZM Position: Q3 2020 in Review

First Trust Advisors sold out of Epizyme, Inc (EPZM) in Q3 2020, closing a stake of 46,148 shares — an estimated $741K sold.

First Trust Advisors first reported a position in EPZM in Q2 2018 and held it in 4 quarters. The position peaked at $1.83M in Q1 2020. 151 funds tracked by Wall St. Rank hold EPZM as of Q3 2020.

  • First Trust Advisors reported no remaining Epizyme, Inc position as of Q3 2020 after selling out during the quarter.
  • First Trust Advisors sold 46,148 Epizyme, Inc shares in Q3 2020, an estimated $741K.
  • First Trust Advisors first reported a position in Epizyme, Inc in Q2 2018 and held it in 4 quarters.
  • First Trust Advisors's Epizyme, Inc position peaked at $1.83M in Q1 2020.
  • 151 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2020.

Based on First Trust Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.